COMMON STOCK PURCHASE WARRANT Taronis Technologies, INC.Common Stock Purchase Warrant • February 8th, 2019 • Taronis Technologies, Inc. • Special industry machinery, nec • New York
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_______________________]., a [____] corporation or assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, on the Initial Exercise Date (as defined below) and on or prior to 5:00 PM (Eastern time) on the date that is five years from the Closing Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Taronis Technologies, Inc. f/k/a MagneGas Applied Technology Solutions, Inc., a Delaware corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1(b). Capitalized terms used and not otherwise defined herein shall have the meanings set forth in Se
10,800,000 Shares of Common Stock and Warrants to Purchase 8,100,000 Shares of Common Stock TARONIS TECHNOLOGIES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 8th, 2019 • Taronis Technologies, Inc. • Special industry machinery, nec • New York
Taronis Technologies, Inc. f/k/a MagneGas Applied Technology Solutions, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein (this “Agreement”), to sell to you, Maxim Group LLC (“Maxim” or the “Underwriter”), an aggregate of 10,800,000 shares of the Company’s common stock (the “Common Stock”), $0.001 par value per share (the “Shares”) and warrants to purchase 8,100,000 shares of Common Stock (the “Warrants,” together with the Shares, the “Securities”). In addition, the Company proposes to grant to the Underwriter an option to purchase up to an additional 1,120,000 shares of Common Stock (the “Option Shares”) and/or Warrants to purchase up to an additional 840,000 shares of Common Stock (the “Option Warrants”) from the Company for the purpose of covering over-allotments in connection with the sale of the Securities (collectively, the “Option Securities”). The Securities and the Option Securities are collectively referred to herein
